Codon Capital is a venture capital firm that brings entrepreneurs and researchers to discover strategies for translating innovation into products and startup companies. It focuses on two biology disciplines, Therapeutics and Synthetic Biology, each with unique investment benefits. Together, they represent the new biology design revolution,opportunities that will define healthcare, and agriculture.
Deal activity and portfolio updates would appear here
Connect your data source to see recent transactions